Bing Li

5PUBLICATIONS
12CO-AUTHORS
Haematological tumoursMedical infection agents (incl. prions)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|Oct 15, 2026
Clinical Characteristics of Coexistent Chronic Myeloid Leukemia and BCR::ABL1 Negative Myeloproliferative Neoplasms: A Retrospective Study.

|Jun 18, 2026
Impact of U2AF1 Pathogenic Variants on Prognosis of Myelodysplastic Neoplasms With RUNX1 Mutation.

|Jul 12, 2025
Aberrant splicing of CHEK1 is a driver of megakaryocytic dysplasia in U2AF1S34F mutant myelodysplastic neoplasms.

Wenjun Zhang, Bing Li, Jinqin Liu

|May 07, 2024
Predicting survival in patients with myelodysplastic/myeloproliferative neoplasms with SF3B1 mutation and thrombocytosis.

Fuhui Li, Tiejun Qin, Bing Li

|Apr 14, 2022
BMP2/SMAD pathway activation in JAK2/p53-mutant megakaryocyte/erythroid progenitors promotes leukemic transformation.

Bing Li, Wenbin An, Hua Wang

Pageof 1

Frequent Collaborators

3 joint publications

Zhijian Xiao

2 joint publications

Zhijian Xiao

2 joint publications

Zefeng Xu

1 joint publications

Aishwarya Krishnan